MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NEPH had $1,640K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$1,640K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accrued expenses
    • Change in right-of-use asset
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Selling, general and administrat...
    • Cost of goods sold
    • Research and development
    • Others

Cash Flow
2025-12-31
Total net revenues
18,789
Cost of goods sold
7,164
Gross margin
11,625
Research and development
1,339
Selling, general and administrative
9,000
Other operating expenses
140
Total operating expenses
10,479
Operating income
1,146
Total other income
60
Income tax expense
12
Net income
1,194
Depreciation of property and equipment
55
Amortization of intangible assets, license and supply agreement and finance lease right-of-use asset
84
Stock-based compensation
296
Inventory impairments and writeoffs
68
Change in right-of-use asset
356
(gain) or loss on foreign currency transactions
-5
Accounts receivable
633
Inventory
685
Prepaid expenses and other current assets
35
Accounts payable
259
Accrued expenses
1,024
Lease liabilities
-343
Net cash provided by (used in) operating activities
1,645
Net cash used in investing activities
0
Principal payments on finance lease liability
5
Net cash used in financing activities
-5
Net increase (decrease) in cash and cash equivalents
1,640
Cash and cash equivalents, beginning of year
3,760
Cash and cash equivalents, end of year
5,400
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Total net revenues$18,789K Gross margin$11,625K Canceled cashflow$7,164K Operating income$1,146K Total other income$60K Canceled cashflow$10,479K Cost of goods sold$7,164K Net income$1,194K Accrued expenses$1,024K Canceled cashflow$12K Change in right-of-useasset$356K Stock-based compensation$296K Accounts payable$259K Amortization of intangibleassets, license and...$84K Inventory impairments andwriteoffs$68K Depreciation of property andequipment$55K (gain) or loss onforeign currency...-$5K Total operatingexpenses$10,479K Net cash provided by(used in) operating...$1,645K Canceled cashflow$1,696K Income tax expense$12K Selling, general andadministrative$9,000K Research and development$1,339K Other operatingexpenses$140K Net increase(decrease) in cash and cash...$1,640K Canceled cashflow$5K Inventory$685K Accounts receivable$633K Lease liabilities-$343K Prepaid expenses andother current assets$35K Net cash used infinancing activities-$5K Principal payments onfinance lease liability$5K

NEPHROS INC (NEPH)

NEPHROS INC (NEPH)